Skip to content

APOTHEEK VAN GORP

Active
Public limited companyfounded 198442 yrs activeLuikersteenweg 193, 3500 Hasselt, BelgiumKBO/BCE: BE 0426.258.283
Summary

APOTHEEK VAN GORP has been active since 1984 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €27,549 and a net result of -€16,956. Equity is shrinking by ~5.9% per year across the filed fiscal years. Its solvency ranks better than 14% of 12386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
1 site
Size
€3.3mtotal assets 2025
Staff
3 FTE
Equity
€27,549
Loss
-€16,956
Turnover not published (abridged schema)
Financial health
77 Excellent Checked score 2025
Bankruptcy chance 12 m
0.6%
Structure
Largest shareholder
MANAGEMENT IMMO · 50%
Accounts 79 d early0 of 7 deeds read
Why 77- Equity €27,549 (0.8% of total assets)- Sector Retail trade (NACE 47)+ Size: 3 FTE, total assets €3.3m+ Founded in 1984Show the evidence

Checked score

Score 2025
77 / 100
Excellent
Probability in this band: under 0.55%
Better than 15% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Weak
Solvency 26=
equity 0.8% of total assets
Liquidity 1=
short-term debt 99.2% · cash 0.9%
Profitability 29+4
return on assets -0.5%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,156 companies)
Last 24 months 11-2024: 0.5%lowest value 12-2024: 0.5%● 0.0% vs 11-2024lowest value 01-2025: 0.5%● 0.0% vs 12-2024lowest value 02-2025: 0.6%▲ +2.0% vs 01-2025 03-2025: 0.6%▲ +15.4% vs 02-2025 04-2025: 0.7%▲ +5.7% vs 03-2025 05-2025: 0.7%▲ +0.4% vs 04-2025 06-2025: 0.7%▼ -2.0% vs 05-2025 07-2025: 0.7%● 0.0% vs 06-2025 08-2025: 0.7%● 0.0% vs 07-2025 09-2025: 0.7%● 0.0% vs 08-2025 10-2025: 0.7%● 0.0% vs 09-2025 11-2025: 0.7%● 0.0% vs 10-2025 12-2025: 0.7%● 0.0% vs 11-2025 01-2026: 0.7%● 0.0% vs 12-2025 02-2026: 0.7%▲ +1.9% vs 01-2026 03-2026: 0.8%▲ +17.1% vs 02-2026 04-2026: 0.8%▲ +5.6% vs 03-2026 05-2026: 0.8%▲ +0.5% vs 04-2026highest value 06-2026: 0.6%▼ -33.8% vs 05-2026 07-2026: 0.6%● 0.0% vs 06-2026 08-2026: 0.6%● 0.0% vs 07-2026 09-2026: 0.6%● 0.0% vs 08-2026 10-2026: 0.6%● 0.0% vs 09-2026
  • Equity €27,549 (0.8% of total assets) raises the probability
  • Size: 3 FTE, total assets €3.3m lowers the probability for this profile
  • Sector Retail trade (NACE 47) raises the probability
  • Founded in 1984 lowers the probability for this profile
Credit up to €2,000 at 30 days acceptable
Liquidity short (current ratio 0.5 against 0.49 in 2024; short-term debt: 99.2% and cash: 0.9% of total assets), and 99.2% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 20%, liquidity 3%, profitability 24%, growth against the median 13%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Equity €27,549 (0.8% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Size: 3 FTE, total assets €3.3m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
lowers risk · Founded in 1984
In the bankruptcy model this factor lowers the probability for this profile.
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€16,956
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 12386 sector peers (2025).
NBB · sector comparison
Position among 12386 sector peers
Solvency
better than 14%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-05-2026, 79 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
79 d early
2024
72 d early
2023
75 d early
2022
81 d early
2021
90 d early
2020
67 d early
2019
65 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 76 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
05-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · abbreviated…
  3. Weakest financial yearnet -€40,506

Key points

  • Risk: 3 loss-making years in a rowloss fiscal year 2025 -€16,956 View
  • Caution: Among the weakest 15% on solvencysector median 37.1% · 12,386 companies 0.8% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View

By topic

Financials

Fiscal year
2025
Total assets
€3.3m
Loss
-€16,956
Solvency
0.8%
Total assets▼ 1.1%
Net result
20182025
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 31-07-2027
  1. 13-05-2026Annual accounts filed
  2. 20-05-2025Annual accounts filed
  3. 31-12-2024Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
27-09-1984
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.